Tag: Health Care

Displaying 1 - 20 of 1241 results.

Pages

Federal Trade Commission staff submitted comments to two state legislatures on the impact of legislative proposals to modify the supervision requirements imposed on advanced practice registered nurses, or APRNs.
FTC staff comment concerning Kansas House Bill 2412, a proposal to expand the scope of practice for Advanced Practice Registered Nurses (APRNs) in Kansas. 
Comment by FTC staff concerning Ohio House Bill 177, a proposal to expand the scope of practice of Advanced Practice Registered Nurses (APRNs) in Ohio. 
Following today’s announcement that the parties are abandoning their proposed merger, Gail Levine, Deputy Director of the Bureau of Competition, made this statement:“This deal threatened to let a monopolist extinguish nascent competition in a growing health care market: next-generation DNA...
The Federal Trade Commission has authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California (PacBio). The Commission alleges in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for...
The Federal Trade Commission has closed its investigation into Roche Holding AG’s proposed acquisition of Spark Therapeutics, Inc.
The Federal Trade Commission staff has submitted a comment to the Texas Medical Board raising concerns that the board’s Proposed Rule § 193.13 could harm competition by impeding access to surgical and other health care services that require anesthesia or related services.
The Federal Trade Commission staff has submitted a comment to the North Carolina State Board of Dental Examiners expressing support for proposed changes to the North Carolina Administrative Code that could increase the supply of and access to preventive dental services in underserved areas.
Pharmaceutical and biologic manufacturers Bristol-Myers Squibb Company and Celgene Corporation have agreed to divest Celgene’s Otezla, the most popular oral treatment in the United States for moderate-to-severe psoriasis, for $13.4 billion. The divestiture settles Federal Trade...

Pages